Open AccessEfficacy of cannabis-based medications compared to placebo for the treatment of chronic neuropathic pain: a systematic review with meta-analysis
Author(s) -
Bradley Sainsbury,
Jared Bloxham,
M. Pour,
Mariela Padilla,
Reyes Enciso
Publication year - 2021
Publication title -
journal of dental anesthesia and pain medicine
Language(s) - English
Resource type - Journals
ISSN - 2383-9309
DOI - 10.17245/jdapm.2021.21.6.479
Subject(s) - medicine , cannabidiol , placebo , cannabis , cochrane library , meta analysis , chronic pain , neuropathic pain , randomized controlled trial , medline , tetrahydrocannabinol , subgroup analysis , dronabinol , anesthesia , physical therapy , cannabinoid , psychiatry , alternative medicine , receptor , pathology , political science , law
Chronic neuropathic pain (NP) presents therapeutic challenges. Interest in the use of cannabis-based medications has outpaced the knowledge of its efficacy and safety in treating NP. The objective of this review was to evaluate the effectiveness of cannabis-based medications in individuals with chronic NP.